about
Systematic Review and Network Meta-Analysis of Randomized Controlled Trials: Comparative Effectiveness and Safety of Direct-Acting Antiviral Agents for Treatment-Naive Hepatitis C Genotype 1Network meta-analysis of randomized controlled trials: efficacy and safety of UDCA-based therapies in primary biliary cirrhosisSystematic review with network meta-analysis: adjuvant therapy for resected biliary tract cancerOptimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysisSecondary prophylaxis of variceal bleeding for cirrhotic patients: a multiple-treatments meta-analysisMiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor MetabolismTransient elastography: a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease.Oral acetyl-L-carnitine treatment in hepatic encephalopathy: view of evidence-based medicine.Artificial neural network accurately predicts hepatitis B surface antigen seroclearance.BMP-7 attenuates liver fibrosis via regulation of epidermal growth factor receptor.Performance of platelet count/spleen diameter ratio for diagnosis of esophageal varices in cirrhosis: a meta-analysis.Clinical utility of acoustic radiation force impulse imaging for identification of malignant liver lesions: a meta-analysis.Upper limits of normal for serum alanine aminotransferase levels in Chinese Han population.LPS pretreatment ameliorates D-galactosamine/lipopolysaccharide-induced acute liver failure in rat.Clinical utility of endoscopic ultrasound elastography for identification of malignant pancreatic masses: a meta-analysis.Meta-analysis of the association between a polymorphism in microRNA-196a2 and susceptibility to colorectal cancer.Association between a lumican promoter polymorphism and high myopia in the Chinese population: a meta-analysis of case-control studies.Systematic review with network meta-analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy.Establishment and Validation of SSCLIP Scoring System to Estimate Survival in Hepatocellular Carcinoma Patients Who Received Curative Liver Resection.Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis.A network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis.Establishment and validation of ALPH-Q score to predict mortality risk in patients with acute-on-chronic hepatitis B liver failure: a prospective cohort studyIncreased levels of systolic blood pressure within the normal range are associated with significantly elevated risks of nonalcoholic fatty liver diseaseNonalcoholic fatty liver disease: a negative risk factor for colorectal cancer prognosis.Association between sex-specific serum uric acid and non-alcoholic fatty liver disease in Chinese adults: a large population-based study.Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer.Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.Conditional survival estimate of acute-on-chronic hepatitis B liver failure: a dynamic prediction based on a multicenter cohortDicer interacts with SIRT7 and regulates H3K18 deacetylation in response to DNA damaging agents.Prognostic value of DNA repair based stratification of hepatocellular carcinomaIncreased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease.National incidence of autoimmune liver diseases and its relationship with the human development index.AKI-CLIF-SOFA: a novel prognostic score for critically ill cirrhotic patients with acute kidney injury.Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis.Scoring systems predict the prognosis of acute-on-chronic hepatitis B liver failure: an evidence-based review.Factors associated with efficacy of pegylated interferon-α plus ribavirin for chronic hepatitis C after renal transplantation.The role of fibroblast growth factor 21 in the pathogenesis of liver disease: a novel predictor and therapeutic target.Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target.Systematic review with network meta-analysis: adjuvant chemotherapy for resected colorectal liver metastases.A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
P50
Q26768128-CEE6C8ED-A443-4690-966A-B8194D3B601AQ26824664-5648DC8F-C937-438D-AB64-38CAD281E83FQ26864932-E187B66B-0F76-4674-9BC5-17A2711CED99Q28087211-86C3128D-4244-4C22-8037-7564DEDA9FE0Q28291828-7ACD6F2A-5C5E-4631-A2F0-EFC1EB99324FQ28551765-20FC8918-B085-4EB8-9C96-80096423527BQ31090448-B3AF48BE-2DA5-48DB-9683-12A8D5192353Q31137291-984967D5-F45B-402E-93FE-CADB42B01725Q33734215-11A1DD85-1AA3-4528-B271-E0A51ECDF889Q34028856-B7758265-94AD-461A-85B9-E03A54CEFFC3Q34172693-F22871A2-C219-4FF4-92E7-1A2C2CD93A09Q34330112-81B2D484-D18D-4290-9834-734CF4BAE387Q34409744-E4C66F24-3E35-4EC7-92DB-799DB7FC222BQ34733425-B0B08FA8-1E45-4CDF-9F00-8546A24064C0Q34753119-1C36460E-ADEA-4730-BBF8-5E062B546085Q35012706-460479D3-F308-4695-A701-11679A786A6BQ35091136-A932C0B7-CBBA-4800-942A-165F35BBD2B4Q35561845-19ECFF22-9475-4A50-8E15-1096B6C6A561Q35658230-2C6E0F98-76C0-4EEE-AFB2-6F60E6A9A865Q35660038-3FAD4CAB-0B9A-4E75-A4E8-7DAB6D6B0B63Q35778052-AB0D829F-F7AD-422F-A8CC-8FFC5A64577FQ36151463-51B4ACF5-0148-4053-BC0A-9DC6AFA250CCQ36151646-0B0A57CF-DCD6-45D0-829B-BBF473586A62Q36152268-CF5F8614-0BB1-4014-97D5-602B6083EEFCQ36153675-5298758F-E5EA-4305-B9C5-0BB109FE6E4EQ36260667-1AC91A48-335F-42A2-BF04-14249B9DF6DCQ36413124-3B0E40F8-6E82-4CB8-BE0F-4F22E8BDBEAAQ36414158-02F9D1AC-F5A7-47FE-85F5-561900969B73Q36870468-08C6A763-630E-4717-AE1B-9674F53556D7Q36903275-3137ED2E-9CC9-455B-BD01-44E57541D8AAQ36905761-DA6DE1FE-1685-4D41-BE32-BC81B5B8ADF8Q37564713-577C1E7F-60EA-4CB7-A873-D5F2ED2205BAQ37643523-8662219D-79DA-435C-B72B-D7D5F7555CE9Q38020432-984EB2EB-6709-42B8-A1AB-E114DEAC2188Q38206836-56E0033E-CB43-41B5-818A-5A31E6D8C9E0Q38209120-6D6E2D08-3F9C-4E93-B06B-0DEF244C2582Q38235454-3AB96653-BB73-4FAB-890E-36D7A612758DQ38303270-46466AAD-0AC3-4339-B4AF-41EAA834D434Q38311380-658838B6-6973-443F-B430-F5A35B254F18Q38373951-77A125BE-DE2C-490F-BD99-D1B8FE0B16EF
P50
description
researcher ORCID ID = 0000-0002-5070-3834
@en
wetenschapper
@nl
name
Keqing Shi
@ast
Keqing Shi
@en
Keqing Shi
@es
Keqing Shi
@nl
type
label
Keqing Shi
@ast
Keqing Shi
@en
Keqing Shi
@es
Keqing Shi
@nl
prefLabel
Keqing Shi
@ast
Keqing Shi
@en
Keqing Shi
@es
Keqing Shi
@nl
P106
P31
P496
0000-0002-5070-3834